Tirzepatide
Everything Texas patients need to know about Tirzepatide — how it works, what it costs, who qualifies, expected results, and where LeenRx serves it across the DFW metroplex.
Browse the topic
Frequently Asked
What is Tirzepatide?
Tirzepatide is a once-weekly GLP-1 + GIP receptor agonist FDA-approved for type 2 diabetes and chronic weight management. It works by reducing appetite, slowing gastric emptying, and improving insulin response — typically producing 15-22% body weight loss over 12 months.
How much does Tirzepatide cost in Texas?
Brand Mounjaro/Zepbound runs $900-$1,300/month without insurance. LeenRx offers compounded Tirzepatide starting at $59 for the first month and transparent monthly plans after — no insurance required.
Who qualifies for Tirzepatide?
Adults with BMI ≥ 30, or BMI ≥ 27 with weight-related comorbidities (high blood pressure, sleep apnea, prediabetes, PCOS) typically qualify. A board-certified Texas provider reviews every assessment before any prescription is issued.
What side effects are common?
Mild nausea, fatigue, constipation, and reduced appetite during the first 4–8 weeks while the dose titrates up. Serious side effects are rare and your LeenRx provider monitors you the entire way.
How does Tirzepatide compare to Semaglutide?
Tirzepatide hits both the GLP-1 and GIP receptors (Semaglutide is GLP-1 only), which is why head-to-head trials show meaningfully greater weight loss on average — roughly 20% body weight at the highest doses vs. ~15% for Semaglutide.
